Acadia Healthcare Company Inc vs BioNTech SE - ADR — how do they compare? Acadia Healthcare Company Inc trades at $31.35 (market cap $2.90B), while BioNTech SE - ADR trades at $92.8 (market cap $23.31B). The key difference: BioNTech SE - ADR is far larger — about 8× Acadia Healthcare Company Inc's market cap, and Acadia Healthcare Company Inc is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| ACHC | BNTX | |
|---|---|---|
Market Cap | $2.90B | $23.31B |
Sector | Health | Health |
52-Week High | $35.61 | $119.34 |
52-Week Low | $11.68 | $83.89 |
Enterprise Value | $5.29B | $6.60B |
Trailing returns across standard periods
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →